340B is not the driver of high drug prices. The pharmaceutical corporations' unlimited power to set the list price is the driver.
Editor's note · Context
Schakowsky argues that pharmaceutical companies, not the 340B program, are responsible for high drug prices.
Share
More from Janice Schakowsky
I thank the gentleman for yielding to me for the privilege of saying a few words about Bill Pascrell. I love Bill Pascrell. I say that in the present tense because every time I think of him he makes me smile, not because he was a funny…
Let’s be clear: Medicare Advantage is not Medicare. These private insurance plans use Medicare’s trusted name while too often denying medically necessary care, restricting providers, and overcharging taxpayers by billions. That is…
President Trump’s announcement of ‘major combat operations’ was not authorized by Congress, and I fully support a bipartisan War Powers resolution to reclaim our constitutional authority over matters of war.
We must return to diplomacy, uphold Congress’s authority, and prioritize the safety of U.S. service members and civilians above all else.





